| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 1605 |
| 1 | FUROSEMIDE | 1513 |
| 2 | PREDNISOLONE | 1486 |
| 3 | PREDNISOLONE ORAL | 1486 |
| 4 | PREDNISOLONE ORAL SOLUTION | 1486 |
| 5 | PEMBROLIZUMAB | 1400 |
| 6 | METHOTREXATE | 1382 |
| 7 | NIVOLUMAB | 1235 |
| 8 | CYCLOPHOSPHAMIDE | 1196 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 1196 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ECHINACEA (ANGUSTIFOLIA), TABEBUIA IMPETIGINOSA, HYDRASTIS CANADENSIS, GLANDULA SUPRARENALIS SUIS, THYMUS (SUIS), THYROIDINUM (SUIS), ARSENICUM ALBUM, BRYONIA (ALBA), COCCULUS INDICUS, COLCHICUM AUTUMNALE, LEDUM PALUSTRE, MERCURIUS CYANATUS, NATRUM SULPHURICUM, PULSATILLA (PRATENSIS), SEPIA, SILICEA, AFLATOXIN (B1) | 68 | 0.0963 |
| 1 | GLUTATHIONE | 109 | 0.0632 |
| 2 | VANCOMYCIN HYDROCHLORIDE | 441 | 0.0528 |
| 3 | TOREMIFENE CITRATE | 22 | 0.0510 |
| 4 | MIGLITOL | 49 | 0.0510 |
| 5 | CASPOFUNGIN ACETATE | 75 | 0.0473 |
| 6 | EPIRUBICIN HYDROCHLORIDE | 274 | 0.0422 |
| 7 | CROTAMITON | 25 | 0.0407 |
| 8 | NALDEMEDINE | 54 | 0.0325 |
| 9 | SORAFENIB | 668 | 0.0323 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 3413 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2482 |
| 2 | Platinum-based Drug [EPC] | 1934 |
| 3 | Kinase Inhibitor [EPC] | 1909 |
| 4 | Proton Pump Inhibitor [EPC] | 1601 |
| 5 | Loop Diuretic [EPC] | 1589 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 1552 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 1535 |
| 8 | Alkylating Drug [EPC] | 1465 |
| 9 | Osmotic Laxative [EPC] | 1413 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Complement C5 Inhibitor [EPC] | 8 | 0.0661 |
| 1 | Tricyclic Antidepressant [EPC] | 14 | 0.0292 |
| 2 | Vasopressin V2 Receptor Antagonist [EPC] | 357 | 0.0239 |
| 3 | Complement Factor D Inhibitor [EPC] | 7 | 0.0226 |
| 4 | Human Immunoglobulin [EPC] | 1 | 0.0196 |
| 5 | Bile Acid [EPC] | 420 | 0.0182 |
| 6 | Complement 5a Receptor Antagonist [EPC] | 123 | 0.0182 |
| 7 | Antithrombin-directed RNA Interaction [EPC] | 1 | 0.0179 |
| 8 | alpha-Glucosidase Inhibitor [EPC] | 86 | 0.0176 |
| 9 | Benzodiazepine Antagonist [EPC] | 14 | 0.0158 |